The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

Abbott has received U.S. Food & Drug Administration approval to launch a deep brain stimulation system (DBS) that the company touts as the world's smallest rechargeable device of its kind, the medical ...

(RTTNews) - Abbott (ABT) announced the FDA has granted Breakthrough Device Designation to investigate the use of its deep brain stimulation system in treatment-resistant depression. Abbott's DBS ...

DOI: Beta Oscillation Detector Design for Closed-Loop Deep Brain Stimulation of Parkinson’s Disease with Memristive Spiking Neural Networks Researchers at Michigan Technological University are ...

The US Food and Drug Administration (FDA) has approved Medtronic's technologically advanced deep brain stimulation (DBS) system designed to more precisely target motor symptoms in Parkinson's disease, ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode ...

Abbott Laboratories has won breakthrough device designation for its deep brain stimulation (DBS) system to be investigated in the use of treatment-resistant depression (TRD). The Abbott Park, IL-based ...